YOLFTbeta
31

Cell Bio Human Tech Co.,Ltd

318160 · KQ · Consumer Defensive / Household & Personal Products

5,550.00KRW+240.00 (+4.52%)

Price History

Full chart

Market Stats

Previous Close5,310.00
Open5,520.00
Day Range5,320.00 – 5,630.00
52-Week Range4,960.00 – 11,200.00
Volume7.59K
Market Cap55.52B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.13
50-Day Avg6,632.20
200-Day Avg6,999.75

About

Cell Bio Human Tech Co.,Ltd develops nonwoven fabric materials for sheet masks in Korea and Vietnam. The company provides sheet masks, patches, skincare products, etc. Its nonwoven fabric materials include PT CELL, a cellulose sheet made from bamboo; SEMI GEL and NC Cell, which are made of lyocell material; and SCell, which is made of rayon material, as well as cotton, microfiber, and PET. The company also offers dried hydrogel sheets and dried biocellulose fabrics. Cell Bio Human Tech Co.,Ltd was founded in 2015 and is headquartered in Ansan-si, South Korea.

Company Details

  • SectorConsumer Defensive
  • IndustryHousehold & Personal Products
  • CEOMr. KwonSun Lee
  • Headquarters#2101, 401 Simin-daero, Ansan-si, South Korea, Korea
  • Websitehttps://cellbiohumantech.co.kr

Leadership

  • Mr. KwonSun LeeCEO & Director · b. 1973
  • Mr. DongGyun ChaExecutive Director · b. 1961
  • CheolWoo SonExecutive Director · b. 1975
  • Mr. YongHo ChaExecutive Director · b. 1975

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue27.54B27.32B28.42B51.07B
Growth (%)--0.80%+4.01%+79.69%
Cost of Revenue19.90B19.60B19.37B32.22B
Gross Profit7.64B7.73B9.04B18.85B
Gross Margin27.75%28.28%31.83%36.90%
Operating Expense4.11B4.58B5.01B9.53B
Operating Income3.53B3.15B4.04B9.32B
Operating Margin12.83%11.53%14.20%18.25%
EBITDA5.86B1.48B7.51B11.74B
EBITDA Margin21.26%5.42%26.42%22.98%
Net Income2.89B-1.86B4.38B8.72B
Net Income Margin10.49%-6.80%15.41%17.08%
R&D742.09M656.59M486.14M684.43M
R&D as % of Total Revenue2.69%2.40%1.71%1.34%
Interest Expense454.76M489.03M411.21M319.51M
Interest Expense % of Total Revenue1.65%1.79%1.45%0.63%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets45.98B53.20B52.90B88.46B
Total Liabilities13.83B8.63B6.49B29.45B
Total Equity32.15B44.56B46.41B56.74B
Cash4.49B4.05B3.10B15.92B
Net Debt447.80M1.82B575.62M4.10B

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow437.80M1.76B9.27B1.49B
Capital Expenditure374.95M1.13B2.03B6.81B
Free Cash Flow62.86M626.55M7.24B-5.32B
FCF to OCF14.36%35.61%78.15%-357.95%

Earnings

Report DateJun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------
EPS Actual-199.4748.20-108.8869.9189.92193.76229.32163.07177.77383.47269.35227.71350.26
Surprise-------------
Timing-------------

Key Statistics & Ratios

Market Cap55.52B
Enterprise Value68.25B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.91
Price / Book0.96
Revenue (TTM)60.90B
Gross Profit (TTM)20.32B
EBITDA12.80B
Profit Margin17.35%
Operating Margin18.01%
Return on Equity18.92%
Return on Assets8.35%
Shares Outstanding8.25M
Shares Float4.87M
Beta0.13
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%